Verseon Corporation Additional Listing & Total Voting Rights (0693V)
04 April 2019 - 5:01PM
UK Regulatory
TIDMVERS
RNS Number : 0693V
Verseon Corporation
04 April 2019
April 4, 2019
Verseon Corporation
("Verseon" or the "Company")
Additional Listing & Total Voting Rights
Fremont, Calif.-Verseon, a technology-based pharmaceutical
company, announces that application has been made for 171,974 new
shares of common stock ("Common Shares") of par value $0.001 each
to be admitted to trading on AIM pursuant to regularly scheduled
vesting of restricted stock units and grant of restricted stock
award (the "Issuance").
Of the 171,974 Common Shares issued, 8,474 shares were issued to
Dr. Hecht, and 150,000 of the Common Shares were issued to Dr. Kim,
both non-executive Directors of the Company, in relation to the
payment of their Director's fees. Dr. Kim's shares are subject to a
period of restriction of three years starting on November 5, 2018,
the day Dr. Kim joined Verseon's Board of Directors, and expiring
with respect to 1/12 of the shares at the end of each three-month
period.
Following the Issuance, Dr. Hecht will hold 98,517 Common
Shares, representing 0.06% of the Company's issued share capital
and Dr. Kim will hold 150,000 Common Shares representing 0.09% of
the Company's issued share capital.
The 171,974 new Common Shares issued pursuant to the Issuance
will rank pari passu with the Company's existing Common Shares and
admission to trading on AIM is expected to take place on April 9,
2019 ("Admission").
Total Voting Rights
Following Admission, the issued share capital of the Company
will consist of 159,571,387 Common Shares and the Company will hold
42,917 shares in treasury. Therefore, the total number of Common
Shares in the Company with voting rights will be 159,528,470. This
figure may be used by shareholders in the Company as the
denominator for the calculations by which they will determine if
they are required to notify their interest in, or a change in their
interest in, the share capital of the Company under the FCA's
Disclosure and Transparency Rules.
-Ends-
For further information, please contact
Verseon Corporation www.verseon.com
+1 (510) 225
Sebastian Wykeham / Tina Schlafly 9000
Arden Partners (NOMAD and Joint Broker)
Ruari McGirr / Ciaran Walsh/ Alex +44 (0) 20 7614
Penny 5900
Cantor Fitzgerald Europe (Joint Broker)
+44 (0) 20 7894
Phil Davies 7000
For financial and business media enquiries, please contact
Buchanan Communications Ltd (PR Advisers)
+44 (0) 20 7466
Henry Harrison-Topham / Jamie Hooper 5000
For trade and pharma media enquiries, please contact
Vane Percy & Roberts
+44 (0) 1737
Simon Vane Percy 821 890
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Dr. Thomas Hecht
------------------------------ ------------------------------------
2 Reason for the notification
--------------------------------------------------------------------
a) Position/status Non-Executive Chairman
------------------------------ ------------------------------------
b) Initial notification Initial notification
/Amendment
------------------------------ ------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
--------------------------------------------------------------------
a) Name Verseon Corporation
------------------------------ ------------------------------------
b) LEI 213800CB2DUHDL6EPW12
------------------------------ ------------------------------------
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
--------------------------------------------------------------------
a) Description of the Restricted stock grant of Common
financial instrument, Shares of par value $0.001
type of instrument
Identification code ISIN: USU9221J1098
------------------------------ ------------------------------------
b) Nature of the transaction Vesting of restricted stock units
------------------------------ ------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
Nil 8,474
----------
------------------------------ ------------------------------------
Aggregated information
- Aggregated volume 8,474
d) - Price -
------------------------------ ------------------------------------
e) Date of the transaction 31 March 2019
------------------------------ ------------------------------------
f) Place of the transaction N/a
------------------------------ ------------------------------------
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Dr. Sangtae Kim
------------------------------ ------------------------------------
2 Reason for the notification
--------------------------------------------------------------------
a) Position/status Non-Executive Director
------------------------------ ------------------------------------
b) Initial notification Initial notification
/Amendment
------------------------------ ------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
--------------------------------------------------------------------
a) Name Verseon Corporation
------------------------------ ------------------------------------
b) LEI 213800CB2DUHDL6EPW12
------------------------------ ------------------------------------
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
--------------------------------------------------------------------
a) Description of the Restricted stock grant of Common
financial instrument, Shares of par value $0.001
type of instrument
Identification code ISIN: USU9221J1098
------------------------------ ------------------------------------
b) Nature of the transaction Restricted Stock Award
------------------------------ ------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
Nil 150,000
----------
------------------------------ ------------------------------------
Aggregated information
- Aggregated volume 150,000
d) - Price -
------------------------------ ------------------------------------
e) Date of the transaction 2 April 2019
------------------------------ ------------------------------------
f) Place of the transaction N/a
------------------------------ ------------------------------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
MSCEAALDEANNEAF
(END) Dow Jones Newswires
April 04, 2019 02:01 ET (06:01 GMT)
Verseon (LSE:VERS)
Historical Stock Chart
From Apr 2024 to May 2024
Verseon (LSE:VERS)
Historical Stock Chart
From May 2023 to May 2024